Commercial leaders vs. other companies in European biotech 2014
This statistic depicts the company data of commercial leaders vs. other companies in European biotechnology in 2014. The revenues of commercial leaders amounted to some 19.4 billion U.S. dollars in 2014, while at the same time revenues of other companies in this sector came to approximately 4.6 billion U.S. dollars.
